Literature DB >> 206547

Inhibition of Ca2+-activated cyclic nucleotide phosphodiesterase reaction by a heat-stable inhibitor protein from bovine brain.

R K Sharma, E Wirch, J H Wang.   

Abstract

An inhibitor protein of cyclic nucleotide phosphodiesterase is demonstrated in bovine brain extract and separated from modulator binding protein, a recently discovered inhibitory factor of phosphodiesterase. The new inhibitor protein is similar to the cyclic AMP phosphodiesterase inhibitor from bovine retina (Dumler, I. L., and Etingof, F. N. 1976) Biochim. Biophys, Acta 429, 474-484) in its heat stability: it retains full activity upon heating in a boiling water bath for 2 min. The new inhibitor protein counteracts the activation of the Ca2+-activatable cyclic nucleotide phosphodiesterase by the Ca2+-dependent modulator protein without affecting the basal activity of the enzyme. The inhibition of phosphodiesterase by the inhibitor can be reversed by high concentrations of modulator protein but is not influenced by a 20-fold increase in Ca2+ concentration. In contrast, a Ca2+-independent form of cyclic nucleotide phosphodiesterase is not inhibited by the inhibitor protein. These results suggest that the heat-stable inhibitor protein is specific against the action of the Ca2+-dependent modulator protein. Gel filtration analyses on Sephadex G-75 and G-100 columns have shown that the inhibitor protein and the modulator protein may associate in the presence of Ca2+. The molecular weights determined by the gel filtration for the free inhibitor protein and the complex of the inhibitor and modulator protein are about 70,000 and 85,000, respectively.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206547

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Molecular analysis of cDNA clones and the corresponding genomic coding sequences of the Drosophila dunce+ gene, the structural gene for cAMP phosphodiesterase.

Authors:  C N Chen; S Denome; R L Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  Novel protein inhibitor of calmodulin-dependent cyclic nucleotide phosphodiesterase from glioblastoma multiforme.

Authors:  S Lal; R V Raju; R K Sharma
Journal:  Neurochem Res       Date:  1998-04       Impact factor: 3.996

3.  Effects of streptozotocin-induced diabetes on calmodulin and cyclic AMP phosphodiesterase activity in rat lungs.

Authors:  A F Ofulue; M S Nijjar
Journal:  Lung       Date:  1982       Impact factor: 2.584

Review 4.  Calmodulin.

Authors:  Y M Lin
Journal:  Mol Cell Biochem       Date:  1982-06-11       Impact factor: 3.396

5.  Stimulation by cyclic GMP of sodium efflux in barnacle muscle fibres.

Authors:  E E Bittar; D M Sharp
Journal:  J Physiol       Date:  1979-08       Impact factor: 5.182

6.  Calmodulin-dependency of human neutrophil phosphodiesterase.

Authors:  T Engerson; J L Legendre; H P Jones
Journal:  Inflammation       Date:  1986-03       Impact factor: 4.092

7.  Calmodulin in brain of schizophrenics.

Authors:  F Vargas; A Guidotti
Journal:  Neurochem Res       Date:  1980-06       Impact factor: 3.996

Review 8.  Ion binding to calmodulin. A comparison with other intracellular calcium-binding proteins.

Authors:  M C Kilhoffer; J Haiech; J G Demaille
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

9.  Ca2+-independent cyclic GMP phosphodiesterases from rat liver and HTC hepatoma cells.

Authors:  G J Strewler; M A Danello; V C Manganiello; M Vaughan
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

10.  Calmodulin activation of rat lung adenylate cyclase is independent of the cytoplasmic factors modulating the enzyme.

Authors:  A F Ofulue; M S Nijjar
Journal:  Biochem J       Date:  1981-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.